Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,736 public trials 631 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema

NCT02079688

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations: Division for Immunodermatology and Allergy Research Clinic for Dermatology, Allergy and Venereology Hannover Medical School Hanover, Germany

View Trial Details

Completed

Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study

NCT02729012

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council Palermo, Sicily, Italy

View Trial Details

Completed

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

NCT01436071

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Newport Beach, California, United States

GSK Investigational Site Albany, Georgia, United States

View all 24 locations

View Trial Details

Completed

Immune Response to Varicella Vaccination in Children With Atopic Dermatitis

NCT00406081

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: National Jewish Health Denver, Colorado, United States

Children's Hospital Boston Boston, Massachusetts, United States

View Trial Details

Completed

Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study

NCT01453023

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Huntington Beach, California, United States

View Trial Details

Completed

Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

NCT01630135

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: GSK Investigational Site Chiba, Japan

GSK Investigational Site Chiba, Japan

GSK Investigational Site Chiba, Japan

GSK Investigational Site Chiba, Japan

View all 22 locations

View Trial Details

Completed

A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma

NCT01244984

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Chiba, Japan

GSK Investigational Site Fukuoka, Japan

GSK Investigational Site Fukuoka, Japan

GSK Investigational Site Gifu, Japan

View all 30 locations

View Trial Details

Completed

Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

NCT01134042

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Bell Gardens, California, United States

GSK Investigational Site Huntington Beach, California, United States

GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Los Angeles, California, United States

View all 71 locations

View Trial Details

Completed

Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils

NCT01366521

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Winston-Salem, North Carolina, United States

GSK Investigational Site Pittsburgh, Pennsylvania, United States

GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

View Trial Details

Completed

Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

NCT00614731

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: National Jewish Health Denver, Colorado, United States

View Trial Details

Hypersensitivity, Immediate

Hypersensitivity, Immediate trial results

Related conditions